238 related articles for article (PubMed ID: 33589753)
1. Two decades of targeted therapies in acute myeloid leukemia.
Cucchi DGJ; Polak TB; Ossenkoppele GJ; Uyl-De Groot CA; Cloos J; Zweegman S; Janssen JJWM
Leukemia; 2021 Mar; 35(3):651-660. PubMed ID: 33589753
[TBL] [Abstract][Full Text] [Related]
2. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
3. New Food and Drug Administration-Approved and Emerging Novel Treatment Options for Acute Myeloid Leukemia.
Click ZR; Seddon AN; Bae YR; Fisher JD; Ogunniyi A
Pharmacotherapy; 2018 Nov; 38(11):1143-1154. PubMed ID: 30220082
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.
Short NJ; Konopleva M; Kadia TM; Borthakur G; Ravandi F; DiNardo CD; Daver N
Cancer Discov; 2020 Apr; 10(4):506-525. PubMed ID: 32014868
[TBL] [Abstract][Full Text] [Related]
5. Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia.
Luskin MR; DeAngelo DJ
Expert Rev Hematol; 2017 Dec; 10(12):1033-1045. PubMed ID: 29069942
[TBL] [Abstract][Full Text] [Related]
6. New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.
Kopmar NE; Estey EH
Clin Adv Hematol Oncol; 2019 Oct; 17(10):569-575. PubMed ID: 31730583
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
Miyamoto K; Minami Y
Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
[TBL] [Abstract][Full Text] [Related]
8. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted therapy in acute myeloid leukemia.
Gill H; Leung AY; Kwong YL
Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
Naqvi K; Konopleva M; Ravandi F
Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutics in acute myeloid leukemia.
Sweet K; Lancet JE
Curr Hematol Malig Rep; 2014 Jun; 9(2):109-17. PubMed ID: 24633743
[TBL] [Abstract][Full Text] [Related]
12. New treatment for acute myelogenous leukemia.
DiNardo CD; Cortes JE
Expert Opin Pharmacother; 2015 Jan; 16(1):95-106. PubMed ID: 25480777
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute myeloid leukemia in the next decade - Towards real-time functional testing and personalized medicine.
Lam SS; He AB; Leung AY
Blood Rev; 2017 Nov; 31(6):418-425. PubMed ID: 28797519
[TBL] [Abstract][Full Text] [Related]
14. From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia.
Yilmaz M; Daver N
Drugs; 2019 Jul; 79(11):1177-1186. PubMed ID: 31222627
[TBL] [Abstract][Full Text] [Related]
15. Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
Miyamoto K; Minami Y
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698349
[TBL] [Abstract][Full Text] [Related]
16. Novel therapies for AML: a round-up for clinicians.
Swaminathan M; Wang ES
Expert Rev Clin Pharmacol; 2020 Dec; 13(12):1389-1400. PubMed ID: 33412978
[No Abstract] [Full Text] [Related]
17. Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?
Bewersdorf JP; Stahl M; Zeidan AM
Leuk Lymphoma; 2019 Jun; 60(6):1354-1369. PubMed ID: 30652518
[TBL] [Abstract][Full Text] [Related]
18. Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop.
Wang ES; Baron J
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):57-66. PubMed ID: 33275692
[TBL] [Abstract][Full Text] [Related]
19. New and emerging therapies for acute myeloid leukaemia.
Davis JR; Benjamin DJ; Jonas BA
J Investig Med; 2018 Dec; 66(8):1088-1095. PubMed ID: 30127098
[TBL] [Abstract][Full Text] [Related]
20. Incorporating newer agents in the treatment of acute myeloid leukemia.
Raj RV; Abedin SM; Atallah E
Leuk Res; 2018 Nov; 74():113-120. PubMed ID: 30401522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]